Wert202020212022202320242025TTMMittelzufluss aus Investitionstätigkeit-140.52 M-54.47 M114.07 M-3.73 M162.15 M138.67 M82.34 MZahlungsströme aus der Finanzierungstätigkeit224.12 M282.11 M1.28 M118.04 M56.03 M40.47 M41.91 MFreier Cashflow-179.84 M-163.8 M-177.35 M-132.18 M-210.28 M-165.24 M-140.5 M
Editas Medicine, Inc. - Common Stock
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado.